Market Overview:
The global veterinary drug market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for meat and milk products, rising awareness about animal health, and growing concerns about zoonotic diseases. The global veterinary drug market is segmented by type into anti-infectives, anti-inflammatory agents, parasiticides, analgesics, sedatives, and other drugs. The anti-infective segment is expected to grow at the highest CAGR during the forecast period owing to the increasing incidence of infectious diseases in animals. By application, the market is divided into pets (dogs and cats), cattle (beef and dairy cows), poultry (broilers and layers), swine (pigs), and other applications including aquaculture fish farming). The cattle segment accounted for the largest share of the global veterinary drug market in 2017 owing to rising demand for beef products worldwide. Geographically, North America was estimated as having accounted for around one third share of total revenue generated by Veterinary Drug Market globally followed by Europe region with around 27%.
Product Definition:
A veterinary drug is a drug used by veterinarians to treat or prevent diseases in animals. Veterinary drugs are also used to promote growth, improve feed efficiency, and control parasites in livestock.
Anti-Infectives:
Anti-infectives is a group of drugs used to treat bacterial infections. The drug works by destroying the bacteria. Some anti-infective drugs are also used to prevent infections in people and animals. Anti-infectives play an important role in veterinary medicine as they can be used for treating various bacterial diseases of pets, such as skin infection, urinary tract infection (UTI), pneumonia, bone marrow transplant rejection etc., especially dogs and cats.
Anti-Inflammatory:
An inflammatory process is the body's natural response to an injury or a foreign body. Inflammation can be classified as acute and chronic. The most common causes of inflammation are infections, autoimmune diseases, and allergies. An inflammatory process is also known as an immune response; it is part of the adaptive mechanism that enables the body to fight off infection or trauma.
Application Insights:
The pet segment dominated the global market in terms of revenue and accounted for a share of over 40.0% in 2017. The growth can be attributed to the increasing demand for companion animals due to high disposable income levels coupled with rising living standards among all age groups across the globe. Moreover, an increase in spending on veterinary medicines and products is expected to boost product demand globally over the forecast period.
The cattle segment accounted for a significant share in 2017 owing to increased production of milk.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to increasing pet ownership, high disposable income and awareness about animal health. Moreover, the presence of major companies manufacturing veterinary drugs is also contributing toward market growth in North America. For instance, Zoetis; Elanco; Merck & Co.; and Pfizer Inc. are some of the leading players operating in this space that manufactures an array of products for animals including vaccines, medicines for livestock diseases and pets nutrition products such as feed additives and supplements).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising demand from emerging economies such as China India Japan South Korea Indonesia Malaysia Philippines Thailand Vietnam etc.
Growth Factors:
- Increasing demand for meat and dairy products, which is driving the growth of the livestock industry. This in turn is fueling the demand for veterinary drugs and vaccines.
- Rising awareness about animal health and hygiene among farmers, pet owners, and other stakeholders is propelling the growth of the veterinary drug market.
- The increasing prevalence of zoonotic diseases is leading to an increase in demand for veterinary drugs and vaccines worldwide.
- Technological advancements in vaccine development are providing a boost to the global veterinary drug market. For instance, recombinant DNA technology has led to development of novel vaccines that are more effective than traditional ones against various diseases affecting animals such as foot-and-mouth disease (FMD), avian influenza (AI), etcetera). 5) Growing popularity of companion animals (pets) is also contributing significantly to the growth of global Veterinary Drug market
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Drug Market Research Report
By Type
Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others
By Application
Pets, Cattle, Poultry, Swine, Others
By Companies
Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Drug Market Report Segments:
The global Veterinary Drug market is segmented on the basis of:
Types
Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pets, Cattle, Poultry, Swine, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Elanco
- Boehringer Ingelheim
- Merck
- Virbac
- Ceva
- Vetoquinol
- Dechra
- Norbrook
- Phibro
- Huvepharma
- Hipra
- Ouro Fino Saude
- CAHIC
- Orion
- Ringpu Biology
- Nippon Zenyaku Kogyo
- Farmavet-Pasteur
Highlights of The Veterinary Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- By Application:
- Pets
- Cattle
- Poultry
- Swine
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary drug is a medication that is specifically prescribed for use by veterinarians. Veterinary drugs are often more expensive than human medications, and may require special handling in order to prevent contamination.
Some of the major companies in the veterinary drug market are Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur.
The veterinary drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Veterinary Drug Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Veterinary Drug Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Veterinary Drug Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Veterinary Drug Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Veterinary Drug Market Size & Forecast, 2020-2028 4.5.1 Veterinary Drug Market Size and Y-o-Y Growth 4.5.2 Veterinary Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anti-Infectives
5.2.2 Anti-Inflammatory
5.2.3 Parasiticides
5.2.4 Analgesics
5.2.5 Sedatives
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pets
6.2.2 Cattle
6.2.3 Poultry
6.2.4 Swine
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Veterinary Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Veterinary Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anti-Infectives
9.6.2 Anti-Inflammatory
9.6.3 Parasiticides
9.6.4 Analgesics
9.6.5 Sedatives
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pets
9.10.2 Cattle
9.10.3 Poultry
9.10.4 Swine
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anti-Infectives
10.6.2 Anti-Inflammatory
10.6.3 Parasiticides
10.6.4 Analgesics
10.6.5 Sedatives
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pets
10.10.2 Cattle
10.10.3 Poultry
10.10.4 Swine
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anti-Infectives
11.6.2 Anti-Inflammatory
11.6.3 Parasiticides
11.6.4 Analgesics
11.6.5 Sedatives
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pets
11.10.2 Cattle
11.10.3 Poultry
11.10.4 Swine
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anti-Infectives
12.6.2 Anti-Inflammatory
12.6.3 Parasiticides
12.6.4 Analgesics
12.6.5 Sedatives
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pets
12.10.2 Cattle
12.10.3 Poultry
12.10.4 Swine
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anti-Infectives
13.6.2 Anti-Inflammatory
13.6.3 Parasiticides
13.6.4 Analgesics
13.6.5 Sedatives
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pets
13.10.2 Cattle
13.10.3 Poultry
13.10.4 Swine
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Veterinary Drug Market: Competitive Dashboard
14.2 Global Veterinary Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Elanco
14.3.3 Boehringer Ingelheim
14.3.4 Merck
14.3.5 Virbac
14.3.6 Ceva
14.3.7 Vetoquinol
14.3.8 Dechra
14.3.9 Norbrook
14.3.10 Phibro
14.3.11 Huvepharma
14.3.12 Hipra
14.3.13 Ouro Fino Saude
14.3.14 CAHIC
14.3.15 Orion
14.3.16 Ringpu Biology
14.3.17 Nippon Zenyaku Kogyo
14.3.18 Farmavet-Pasteur